| Nov 12 |
Earnings Snapshot: Novavax tops Q3 estimates; lowers FY24 outlook
|
| Nov 12 |
Novavax: Q3 Earnings Snapshot
|
| Nov 12 |
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
|
| Nov 12 |
Novavax beats top-line and bottom-line estimates; updates FY24 outlook
|
| Nov 12 |
Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold
|
| Nov 11 |
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?
|
| Nov 11 |
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trial
|
| Nov 11 |
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
|
